SOPH — SOPHiA GENETICS SA

Nasdaq · Information Technology · IT Services · CIK 1840706 ·
Last close
$5.01
Market Cap
$359.67M
52W High
$5.67
52W Low
$4.01
ADV30
101,471
Next earnings
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom. The company was incorporated in 2011 and is based in Rolle, Switzerland.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 21,688,000 14,749,000 -17,283,000 -19,322,000 156,995,000 65,392,000 111,307,000
Dec 2025 21,707,000 14,692,000 -18,516,000 -19,179,000 163,031,000 70,289,000 115,886,000
Sep 2025 19,462,000 12,907,000 -17,862,000 -20,021,000 163,458,000 81,610,000 102,771,000
Jun 2025 18,323,000 12,270,000 -18,492,000 -22,414,000 177,620,000 94,822,000 100,928,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-35,893,000
Investing CF
$-8,670,000
Financing CF
$30,177,000
CapEx
$-8,620,000
Dividends Paid
$0
Buybacks
EPS Diluted TTM
$-1.12
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-519,276,000
Inventory
$6,351,000
Receivables
$16,525,000
ST Investments
EBIT TTM
$-72,933,000
Pretax Income TTM
$-77,487,000
Interest Exp TTM
$4,554,000
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$81,180,000
EBITDA
$-70,322,000
Free Cash Flow
$-24,592,376
Enterprise Value
$347,369,984
Total Cash
$65,392,000
Total Debt
$62,425,000
Shares Out
71,790,366
Trailing EPS
$-1.18
Book Value
$0.64
ROE
-123.3%
ROA
-29.7%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 77,271,000 -70,906,000 -78,999,000 163,031,000 115,886,000 -35,893,000
Dec 2024 65,173,000 -66,568,000 -62,493,000 155,309,000 58,819,000 -44,515,000
Dec 2023 62,371,000 -74,826,000 -78,981,000 206,156,000 54,714,000 -53,224,000
Dec 2022 47,560,000 -87,823,000 -87,449,000 243,838,000 43,708,000 -70,093,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.56

Peers — same industry

TickerNameMarket CapLastDaily %
SOHU Sohu.com Ltd $362.62M $13.91
BLND Blend Labs, Inc. $351.12M $1.47
TLS TELOS CORP $350.90M $4.69
SMWB SIMILARWEB LTD. $348.65M $3.98
HQ Horizon Quantum Holdings Ltd. $376.91M $11.84

News headlines (Yahoo Finance, 1h cache)

Undervalued Opportunities: Top Penny Stocks To Watch In May 2026
2026-05-21 12:05 · Yahoo
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
2026-05-13 09:00 · Yahoo
SOPHiA GENETICS S.A. Q1 2026 Earnings Call Summary
2026-05-05 20:54 · Yahoo
SOPHiA GENETICS Q1 Earnings Call Highlights
2026-05-05 20:20 · Yahoo
SOPHiA Genetics (SOPH) Q1 2026 Earnings Transcript
2026-05-05 20:03 · Yahoo
BTIG Raises its Price Target on SOPHiA GENETICS (SOPH) to $8
2026-05-05 11:39 · Yahoo
SOPHiA GENETICS Reports First Quarter 2026 Results
2026-05-05 10:45 · Yahoo
Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy?
2026-04-27 12:20 · Yahoo
How The SOPHiA GENETICS (NasdaqGS:SOPH) Narrative Is Shifting With New Fair Value Targets
2026-04-26 18:03 · Yahoo
SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026
2026-04-21 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.